Skye Bioscience SKYE
NASDAQ SKYE
$1.60 -0.01 (-0.62%)
As of: Oct 1, 2026 · 3:59 PM EDT

Skye Bioscience (SKYE) Long-Term Debt Issuances (2013 - 2018)

Updated

Skye Bioscience's Long-Term Debt Issuances was $450,000 in FY2020, down 88.7% from $3.99 million in FY2019.

Analysis

Skye Bioscience (SKYE) Long-Term Debt Issuances (2013 - 2018) Analysis & Trends

From FY2012 onward, Skye Bioscience has reported Long-Term Debt Issuances for 6 years.

  • Long-Term Debt Issuances shows a three-year compound annual growth rate of -3.5% (FY2017 to FY2020).
  • Annual Long-Term Debt Issuances has moved between $400,000 (FY2018) and $3.99 million (FY2019) over five years.
  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $3.99 million in FY2019 (+897.7%), $400,000 in FY2018 (-20.0%) and $500,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Skye Bioscience 7.07 Mn 7.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 400,000.00
Jan 31, 2013 32,000.00
API Access

Skye Bioscience Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=SKYE&period=max&api_key=YOUR_API_KEY